Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ORC6, a novel prognostic biomarker, correlates with T regulatory cell infiltration in prostate adenocarcinoma: a pan-cancer analysis. | BMC Cancer | 2023 | 36978046 | PubTator, text mining | PubMed |
| Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration. | Cancer Med | 2023 | 36952458 | PubTator, text mining | PubMed |
| Mining the potential therapeutic targets for COVID-19 infection in patients with severe burn injuries via bioinformatics analysis. | Int Wound J | 2023 | 36924127 | PubTator, text mining | PubMed |
| Integrative analysis of the role of BOLA2B in human pan-cancer. | Front Genet | 2023 | 36923798 | PubTator, text mining | PubMed |
| Cell cycle exits and U-turns: Quiescence as multiple reversible forms of arrest. | Fac Rev | 2023 | 36923701 | PubTator, text mining | PubMed |
| Identification and validation of a novel ubiquitination-related gene UBE2T in Ewing's sarcoma. | Front Oncol | 2023 | 36910645 | PubTator, text mining | PubMed |
| Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics. | Med Sci Monit | 2023 | 36905103 | PubTator, text mining | PubMed |
| The Role of Histone Modification in DNA Replication-Coupled Nucleosome Assembly and Cancer. | Int J Mol Sci | 2023 | 36902370 | PubTator, text mining | PubMed |
| Separase and Roads to Disengage Sister Chromatids during Anaphase. | Int J Mol Sci | 2023 | 36902034 | PubTator, text mining | PubMed |
| Isogenic Cell Lines Derived from Specific Organ Metastases Exhibit Divergent Cytogenomic Aberrations. | Cancers (Basel) | 2023 | 36900209 | PubTator, text mining | PubMed |
| Liquid biopsy by analysis of circulating myeloma cells and cell-free nucleic acids: a novel noninvasive approach of disease evaluation in multiple myeloma. | Biomark Res | 2023 | 36890597 | PubTator, text mining | PubMed |
| Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning. | Sci Rep | 2023 | 36882493 | PubTator, text mining | PubMed |
| Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma. | Saudi J Biol Sci | 2023 | 36879671 | PubTator, text mining | PubMed |
| Biomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets. | MedComm (2020) | 2023 | 36875159 | PubTator, text mining | PubMed |
| Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer. | Front Pharmacol | 2023 | 36874015 | PubTator, text mining | PubMed |
| Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology. | Front Pharmacol | 2023 | 36874011 | PubTator, text mining | PubMed |
| DNA replication initiation factor RECQ4 possesses a role in antagonizing DNA replication initiation. | Nat Commun | 2023 | 36871012 | PubTator, text mining | PubMed |
| Oncogenic YAP mediates changes in chromatin accessibility and activity that drive cell cycle gene expression and cell migration. | Nucleic Acids Res | 2023 | 36864753 | PubTator, text mining | PubMed |
| A virus-borne DNA damage signaling pathway controls the lysogeny-induction switch in a group of temperate pleolipoviruses. | Nucleic Acids Res | 2023 | 36864746 | PubTator, text mining | PubMed |
| FoxM1 knockdown enhanced radiosensitivity of esophageal cancer by inducing apoptosis. | J Cancer | 2023 | 36860922 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=17